Music |
Video |
Movies |
Chart |
Show |
Efficacy and Safety of Rozanolixizumab to Treat Myasthenia Gravis (CheckRare) View | |
UCB Announces Phase 3 Results for Zilucoplan and Rozanolixizumab in Generalized Myasthenia Gravis (g (HPR) View | |
Updates on Rozanolixizumab and Zilucoplan To Treat Myasthenia Gravis (CheckRare) View | |
UCB Announces Positive Phase 3 Results for Zilucoplan in Generalized Myasthenia Gravis (HPR) View | |
ADAPT analysis: efgartigimod for generalized myasthenia gravis (VJNeurology) View | |
Efgartigimod in patients with generalized myasthenia gravis: ADAPT and ADAPT+ (VJNeurology) View | |
Real-World Experience With C5 Complement Inhibition vs FcRn Antagonism in Myasthenia Gravis (CheckRare) View | |
Efgartigimod Was Well-Tolerated in Patients with Generalized Myasthenia Gravis (Neurology Today) View | |
Patient Experience in Clinical Trials for Myasthenia Gravis (Rare Diseases Clinical Research Network (RDCRN)) View | |
Episode 73 - molnupiravir, Apretude, u0026 Vyvgart (The Rx Daily Dose (The Rx Daily Dose)) View |